[Remote] Clinical Operations Vendor Manager at Abata Therapeutics

Remote

Apply Now

Not SpecifiedCompensation

N/AExperience Level

N/AJob Type

Not SpecifiedVisa

N/AIndustries

Requirements

Knowledge of the drug development process in complex indications for large global programs
Strong understanding of contracting process and ability to negotiate and manage contractual arrangements
Ability to prepare bids, requests for quotes, and proposals
Excellent communication skills with an ability to present to a variety of stakeholders

Responsibilities

Collaborate with business partners to research and evaluate potential vendors based on their capabilities, pricing, and service level agreements
Build strong relationships with key vendors
Conduct ongoing assessment of vendor relationship performance through KPI review, vendor performance trend analysis, and administration/interpretation of stakeholder satisfaction surveys
Drive and improve existing systems and processes
Maintain knowledge of market trends for assigned key vendors
Lead and conduct high visibility and competitive negotiations
Support sourcing policies, contingency plans, and additional strategic initiatives established by the Vendor Strategy & Management Lead
Support Clinical Operations Vendor Sourcing and vendor governance related meetings
Hold vendors accountable to performance goals/agreements
Drive annual third-party vendor spend savings while improving processes and vendor relationships
Closely manage deliverable timelines and cross-functional input to keep reviews, decisions, and initiatives on track
Participate in the continuous improvement process for programs within purview
Lead/participate in vendor strategy and budget discussions
Collaborate on contracts review to verify compliance with MSA, discount structures, and performance requirements

Skills

Abata Therapeutics

Develops therapies for autoimmune diseases

About Abata Therapeutics

Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.

Cambridge, MassachusettsHeadquarters

2021Year Founded

$184.8MTotal Funding

EARLY_VCCompany Stage

BiotechnologyIndustries

11-50Employees

Risks

Intensifying competition from companies like Sangamo Therapeutics may impact Abata's market share.

Stringent FDA scrutiny on manufacturing could delay Abata's clinical trials.

Rising clinical trial costs pose financial risks to Abata's pipeline progression.

Differentiation

Abata focuses on Treg cell therapies for autoimmune diseases like MS and diabetes.

Their lead product, ABA 201, targets type 1 diabetes with remaining beta cell function.

Abata's strategic partnership with ElevateBio enhances their manufacturing capabilities.

Upsides

Recent investment from Bristol Myers Squibb boosts Abata's Treg therapy pipeline development.

FDA's accelerated approval pathways may expedite Abata's clinical trials.

Growing autoimmune disease prevalence increases demand for Abata's innovative treatments.

Land your dream remote job 3x faster with AI

Try Jobo Free